Listed
Stock Code: 140410
| Company Name | (주)메지온 |
| English Name | Mezzion Pharma Co., Ltd. |
| Business Reg. No. | 2048172221 |
| CEO | 박동현 |
| Address | 서울특별시 강남구 삼성로 570 석천빌딩 7층 |
| Industry | 의학 및 약학 연구개발업 |
| Industry Code | 70113 |
| Established | 20020925 |
| Phone | 02-560-8000 |
| Website | - |
| Regular Employees | 18persons |
| Corp. Reg. No. | 1101112615578 |
| Item | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Revenue | - | - | - | - |
| Operating Profit | -38B | -35B | -78B | -57B |
| Net Profit | - | - | - | - |
| Total Assets | 622B | 751B | 512B | 818B |
| Total Liabilities | 169B | 140B | 216B | 190B |
| Total Equity | 453B | 611B | 295B | 628B |
Operating Loss: Op. profit -38B
Debt Ratio Surge (+14pp YoY)
▲ 32.1%
▼ 11.3%
| Name | Position | Role | Comp. (M KRW) |
|---|---|---|---|
| 박동현 | 사내이사 | 경영총괄 | - |
| 채정석 | 사내이사 | 경영자문 | - |
| 김재형 | 사내이사 | 경영자문 | - |
| 곽영국 | 사외이사 | 경영자문 | - |
| Mitchell S. Steiner | 사외이사 | 해외임상자문 | - |
| Ridwan Shabsigh | 사외이사 | 경영자문 | - |
| 구본권 | 사외이사 | 경영자문 | - |
| 오대식 | 감사 | 감사 | - |
| 최범진 | 기타비상무이사 | 경영자문 | - |
| Shareholder | Ownership (%) | Shares Held |
|---|---|---|
| - | ||
| - | ||
| - | ||
| - |
| Regular Employees | 18persons |
| CEO | 박동현 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
Data Quality: 4/10 | Primary Source: DART | Section Coverage: 6/7
| Section | Source: | Status |
|---|---|---|
| Basic Info | DART | Collected |
| Financial Statements | DART | Collected |
| Investment Metrics | Not Collected | Not Collected |
| Officers | DART | Collected |
| Employment | DART | Collected |
| Patents | KIPRIS | Collected |
| Procurement | G2B Procurement | Collected |
| API | Collected | Status |
|---|---|---|
| DART Financial | 2026-02-26 | Collected |
| G2B Procurement | 2026-02-25 | Collected |
| KIPRIS Patents | 2026-02-25 | Collected |
| Employment Insurance | 2026-02-25 | Collected |
| HomeTax Business | 2026-02-25 | Collected |